Among these receptors, it has been identified that the chemokine receptor CCR9 is expressed differentially in the tumor and non-tumor areas, showing a decreased percentage of CCR9+ CD8+ T cells in CRC compared to normal tissue [29]. This evidence concerns the gene CCR9 and neoplasm.